cGxP.wire https://validator.w3.org/feed/docs/rss2.html Lilly Reports One-Year Results for Taltz and Zepbound Waters Wins FDA Clearance for Leukemia Flow Cytometry Tests Lipocine Starts Phase 3 BLOOM Trial for Postpartum Depression Adcendo to Present ADCE-D01 Phase 1 Sarcoma Data Azitra Reports ATR-COSF Results for Wrinkle Reduction Francis Medical Secures J&J Funding to Expand Vanquish Ambrosia Presents Two Oral Obesity Drug Candidates in 2026 Layer Health Wins 2026 Accenture HealthTech Innovation Award 10x Genomics Launches 500-Patient Breast Cancer Study Jubilant Therapeutics Reports Promising JBI-802 Clinical Data Novo Nordisk Commits $200M to Global Diabetes Care Programs Moderna Reports mNEXSPIKE COVID-19 Vaccine Study Results IASO Bio Wins China IND Approval for IASO208 CAR-T CU Anschutz Study Reveals Maternal Effects in Type 1 Diabetes Eli Lilly Highlights Foundayo in New Weight-Health Campaigns Cepheid Gains IVDR CE Mark for Respiratory Panel Curia Expands Precision Fermentation Capacity in Spain Boehringer’s SCOVELLA Gains Positive EU Opinion Alnylam Reports Five-Year AMVUTTRA Benefits in ATTR-CM Eilean Reports First Human MALT1 Degradation Alphyn’s Zabalafin Highlighted in Atopic Dermatitis Review Biond Biologics Doses First Patient in BND-67 Trial HotSpot Therapeutics Reports HST-2011 Preclinical Data Protalix Reports 12-Week Uric Acid Control With PRX-115 Pierre Fabre and XtalPi Partner in AI Drug Discovery UCB Reports Sustained BIMZELX Responses in Psoriatic Arthritis Bayer Wins FDA Approval for Asundexian in Stroke Prevention Boehringer Reports Positive Survodutide Phase III Data Merck Reports Positive Efinopegdutide MASH Trial Data Valneva Reports 94% IXCHIQ Antibody Response at Five Years Actinium Forms Scientific Board to Guide Cancer Pipeline Aisa Pharma Reports Positive Phase II Data for AISA-021 Caris Reveals ESR1 Mutation Insights in Breast Cancer AbelZeta Reports CAR-T Data in Advanced Liver Cancer Lilly’s Foundayo Shows Positive Phase III Sleep Apnea Data ACP and OpenEvidence Partner to Advance Clinical AI Amgen Highlights Earlier Repatha Use at AHA 2026 OrthoTrophix Reports TPX-100 Data in Knee Osteoarthritis SetPoint Medical Reports 24-Month RA Treatment Data Ribo Files EU Phase I Trial for Dual-Targeting SR122 GlycoNex Submits Denosumab Biosimilar SPD8 in Japan InnoCare Advances Mesutoclax in Phase III AML Trial Regeneron’s CIDEB siRNA Cuts Liver Fat in Early Trial Vir Biotechnology Phase 3 Trial Meets Hepatitis Delta Goal BMS Reports 56-Week CAMZYOS Data in Pediatric oHCM Lilac Biosciences Appoints Adriana Coll De Peña as CEO AusperBio Reports 15-Month Hepatitis B Cure With AHB-137 Brii Bio Reports Phase 2 Progress in Hepatitis B Cure ImmunoGenesis Highlights IMGS-203 in Two Cancer Studies Skyhawk Doses First U.S. Patients in Huntington’s Trial